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Urinary tract and renal abnormalities repre-
sent 20% of all congenital malformations [1]. If
undiagnosed before birth, they can lead to pro-
gressive hydronephrosis [2] and/or terminal renal
failure (77% of cases) during infancy.
Systematic ultrasonographic screening allows
the diagnosis of most urinary abnormalities. Thus,
specific neonatal management and long-term fol-
low-up can be planned for each case [3]. When
end-stage renal disease is suspected, fetal renal
function can be evaluated through urinary elec-
trolytes analysis [4–5] and/or fetal blood sampling
[6]. Once the prognosis has been ascertained, pre-
natal invasive treatment can be considered in cases
of bilateral progressive lesions [7–10].
The aim of this study was to describe the per-
tinence of prenatal diagnosis of congenital
uropathies by comparing prenatal data with defin-
itive clinical, surgical, or pathological diagnoses.
Objective: to evaluate the pertinence of prena-
tal diagnosis in cases of congenital uropathy.
Study design: retrospective evaluation over a
period of 6.5 years.
Method: 93 cases were involved in the compar-
ison of prenatal ultrasonographic diagnosis with
neonatal findings, autopsy results, and follow-up
data.
Results: 33 fetuses had renal parenchymal le-
sions, 44 had excretory system lesions, and 6 had
bladder and/or urethral lesions. Seventy-three
pregnancies lead to live births. Eighteen termina-
tions of pregnancy were performed on the parents’
request for extremely severe malformations. Two
intrauterine deaths were observed, and two infants
died in the postnatal period. Prenatal diagnosis was
obtained at an average of 27 weeks’ gestation. Di-
agnostic concordance was excellent in 82% and
partial in 12% of cases with renal parenchymal le-
sions; the false-positive rate was 6%. For excretory
system lesions, concordance was excellent in 87%
and partial in 7.4% of cases, with a false-positive
rate of 5.6%. Finally, concordance was excellent in
100% of cases of bladder and/or urethral lesions.
The overall rate of total concordance was
86%. Partial concordance cases consisted of mal-
formations different from those previously diag-
nosed, but prenatal diagnosis nevertheless lead to
further investigations in the neonatal period and to
proper management. The false-positive diagnoses
(5.4%) never lead to termination of pregnancy.
Conclusion: prenatal diagnosis of congenital
uropathy is effective. A third-trimester ultrasono-
graphic examination is necessary to ensure proper
neonatal management, considering that the ma-
jority of cases are diagnosed at this gestational age.
Keywords: urinary malformations; congenital uro-
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Summary
Introduction
Patients and methods
In this retrospective study, we analysed 105 cases of
urinary tract and renal malformations, prenatally detected
by ultrasonography in our Department between 1990 and
1996. Twelve cases were excluded from the study: eleven
were lost to follow-up right after the neonatal period, and
one did not undergo usual neonatal investigations. Hence,
93 cases were actually included in the study. The majority
of patients (70 of 93) was referred for level III ultrasonog-
raphy. Positive family history was present in 4 of the 93 cases. 
During this period, three ultrasonographic examina-
tions were systematically performed during pregnancy. All
women had the same ultrasonographic screening with 3
When lethal lesions were detected, termination of
pregnancy or palliative neonatal treatment was discussed
with the parents. In all other cases, a multidisciplinary ap-
proach was organised, including paediatricians and paedi-
atric surgeons whom the parents met systematically before
birth. When parents elected to proceed with the preg-
nancy, a regular ultrasonographic follow-up was routinely
initiated.
The management of obstructive lesions is summa-
rized in Figure 1. In cases of bilateral lesions associated
with olygohydramnios, an analysis of the fetal renal func-
tion was performed. It was achieved by urine sampling
under ultrasonographic guidance and measurement of uri-
nary electrolyte concentrations [4–5]. In some cases, fetal
blood sampling was also carried-out in order to measure
serum β2-microglobulin and/or perform a karyotype
analysis [6].
The pertinence of prenatal ultrasonographic screen-
ing was studied by comparing prenatal diagnoses with the
results of pathology examinations, complete neonatal
check-ups (including systematic ultrasonographic imaging
and, in some cases, intravenous pyelogram, voiding cysto-
urethrography or renal scintigraphy), and surgical diag-
noses when available. Neonatal sonograms were per-
formed 4 to 5 days after birth because earlier examinations
are less reliable due to the physiological neonatal hypo-
volemia. Blood analysis and urine culture were also sys-
tematically performed. Detailed postnatal follow-up is de-
scribed in Table 1 [15–16].
When there was perfect agreement between pre- and
postnatal diagnoses, the concordance was considered ex-
cellent. It was considered partial when prenatal ultrasound
incompletely described the patient’s condition. In false-
positive cases, the suspected diagnosis was not confirmed
after birth.
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Figure 1
Management 
of obstructive
uropathies.
Neonatal diagnosis ultrasound renal scintigraphy cysto-urethrography
Pyelo-ureteral stenosis 3 months 3 months –
Vesico-ureteral reflux I-II 1 year 2 years –
Vesico-ureteral reflux III 6 months 1 year 1 year
Uretero-vesical stenosis 3 months 3 months –
Ureterocele 3 months 3 months 3 months
Table 1
Timing of the first
postnatal examinations
according to the
neonatal diagnosis.
Results
Five cases (5.4%) were diagnosed in the first,
35 cases (37.6%) in the second, and 53 cases (57%)
in the third trimester of pregnancy. Mean gesta-
tional age at the time of diagnosis was 27.5 weeks,
and in 63.5% of cases diagnosis was established
after the 22nd week. Fetal urinary abnormalities
were grouped according to their location: kidney
(35.5%), higher urinary tract (58%) and lower uri-
nary tract (6.5%) (Table 2).
Mean gestational age at the time of diagnosis
varied in the different groups: 27.1 weeks [range:
15–40] in higher urinary tract lesions (n = 54); 27.4
weeks [range: 12–40] in renal lesions (n = 33) and
21.8 weeks [range: 12-34] in lower urinary tract le-
sions (n = 6). Fetal karyotype was studied in 22
cases (23.7%). Fetal serum β2-microglobulin and
urine electrolytes were measured in one case. Tri-
somy 18 was observed in one fetus presenting with
early isolated megabladder. 
According to the parents’ wish, termination of
pregnancy was performed in 18 cases at a mean
gestational age of 20.9 weeks [range: 12–31]:
Prune-Belly syndrome (n = 4), Potter syndrome (n
= 4), polycystic kidneys (n = 5), Trisomy 18 (n = 1),
and multiple severe malformations (n = 3). All 18
cases were associated with early anamnios. In-
trauterine death of unknown origin was observed
in two fetuses, for which necropsy findings con-
firmed the prenatal diagnosis.
Obstetrical outcome for the remaining 73 pa-
tients was comparable to our general population.
Instrumental delivery or Cesarean section (24.3%)
was performed on pure obstetrical indications dur-
ing labour. Mean gestational age at delivery was 39
weeks 2 days [range: 26–42]. Mean birth weight was
3323 g [range: 750–4470]. Mean APGAR score was
8.0 [range: 2-10] at 1 minute, 9.1 [range: 2–10] at 5
minutes and 9.4 [range: 2–10] at 10 minutes.
One newborn died after 10 minutes. He was
diagnosed with left renal agenesia and right mul-
scans during pregnancy. The first scan was done at 
12 and 14 weeks in order to ascertain gestational age. The
second and third scans were performed between 22 and 32
weeks. Pyelic dilatation was considered when the antero-
posterior diameter exceeded 5 mm before 32 weeks or 8
mm later in pregnancy [11–14].
ticystic dysplasia as of the 20th week, and suffered
from chronic oligohydramnios. The parents did
not wish to consider termination of pregnancy.
All other infants (n = 72) received prophylac-
tic antibiotherapy and underwent neonatal inves-
tigations as planned. The mean duration of follow-
up was 21.9 months, [range: 3-60] in this popula-
tion.
Conservative management was chosen in 42
cases. The outcome was good for 30 of the 42 in-
fants. One infant having multiple malformations
died at the age of 4 months. Two of the 42 infants
showed a decreased renal function, and one un-
derwent surgical treatment during the follow-up
period. Nine infants out of the forty-two were lost
to follow-up.
Surgical treatment was necessary in 30 cases.
Eighteen Anderson-Hynes pyeloplasties were per-
formed with and without preoperative percuta-
neous drainage for pyeloureteral junction stenosis
associated with hydronephrosis. Unilateral
nephrectomy was performed in 3 infants showing
non functional unilateral multicystic kidney. Four
infants underwent ureteral reimplantation, and
three had endoscopic ureterocele incision and di-
latation of uretero-vesical stenosis. Electrocoagu-
lation of posterior urethral valves was performed
in one case. One infant had to undergo surgery at
age two after failure of the conservative manage-
ment (right nephro-ureterectomy).
Nineteen infants were considered cured and 2
were considered stabilised. In four cases, the renal
function deteriorated despite surgical treatment. A
first infant developed progressive renal failure
three years after being treated for junction steno-
sis (ureterocystoneostomy). A second one treated
for bilateral hydronephrosis due to posterior ure-
thral valves exhibited a significant unilateral de-
crease of the renal function (12%) 5 months after
surgery. A third infant operated on for unilateral
hydronephrosis due to pyeloureteral junction
stenosis showed a slight decrease in renal function.
The fourth one died at 4 months (multiple mal-
formations). Four other infants were lost to follow-
up after surgery.
Agreement between pre- and postnatal 
diagnoses
Concordance was excellent in 82% of renal
parenchymal lesions, in 87% of higher urinary
tract malformations, and in 100% of bladder or
urethra abnormalities. Partial concordance was
observed in 8 of the 93 cases (8.6%), but manage-
ment was unchanged. Partial concordance oc-
curred in 12% of renal parenchymal lesions and
7.4% of higher urinary tract malformations.
Neonatal check-up showed simple pyelic dilata-
tions in two cases of suspected polycystic kidney.
Two prenatally diagnosed isolated renal cysts were
in fact a renal neuroblastoma and a cystic lymph-
angioma. One renal duplication and one multi-
cystic kidney were mistaken for hydronephrosis,
and two suspected pyelic dilatations were in fact
extra-renal pelvis.
False-positive prenatal diagnoses were ob-
served in 6% of renal parenchymal lesions and
5.6% of higher urinary tract malformations. Two
hyperechogenic kidneys and three pyelic dilata-
tions were not confirmed after birth.
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Ultrasonographic diagnosis n liveborn TOP IUD MGAD
Pathology of the renal parenchyma
Multicystic kidney and isolated cyst 6 3 2 1 28.7
Polycystic kidney 16 15 1 0 28.1
Horseshoe kidney 2 2 0 0 25.0
Hyperechogenic kidney 1 1 0 0 26
Renal agenesia 8 1 7 0 22.3
Pathology of higher urinary tract
Hydronephrosis 37 34 2 1 29.5
Pyelic dilatation 15 15 0 0 25.2
Ureterocele 1 1 0 0 27
Ureteral dilatation 1 1 0 0 28
Pathology of the bladder and/or urethra
Prune-Belly syndrome 4 0 4 0 19.4
Megabladder 1 0 1 0 16
Bladder agenesia 1 0 1 0 26
TOP: termination of pregnancy IUD: intrauterine demise MGAD: mean gestational age at the time of diagnosis
Table 2 
Fetal urinary 
abnormalities.
Discussion 
Numerous studies have shown the efficacy of
ultrasonographic screening of fetal malformations
[1–17]. Published data show a significant geo-
graphic variation in the incidence of uropathies de-
tected antenatally by routine ultrasound examina-
tions [18]. Prenatal detection rate also varies ac-
cording to the frequency and timing of ultrasono-
graphic examinations during pregnancy [1], and
the chosen cut-offs for normal values [3].
In our study, bladder and urethra malforma-
tions were detected at an earlier age (21.8 weeks)
compared to other urinary abnormalities. These
lesions are often incompatible with survival and
need to be detected as early as possible if termina-
tion of the pregnancy is to be discussed with the
parents. Higher malformations are diagnosed at a
later age (27 weeks). If the third-trimester ultra-
sonographic examination is not performed, these
lesions will be missed at birth and the infants will
not benefit from adequate prenatal and neonatal
management, which is known to reduce the risk of
renal failure. Diagnosis was established even later
during pregnancy in patients requiring immediate
surgery after birth (29 weeks). Thus, one third of
infants (n = 29) presenting with urinary patholo-
gies would not have been diagnosed without third-
trimester ultrasound, leading to long-term renal
function deterioration. 
In our series, false-positive prenatal diagnosis
never lead to termination of pregnancy, but caused
unnecessary burden of anxiety to the parents. This
retrospective study confirms the pertinence (86%)
of prenatal ultrasonographic examinations. Van-
derstichele et al. [19] described a 78% concordance
in a series of 147 cases. In a large retrospective
study, Droullé et al. [20] found that prenatal diag-
nosis was correct in 87% of cases. Sanghvi et al.
[17] reported 81.5% concordance for at least one
ultrasonographic examination performed between
20 and 37 weeks gestation. As compared to cardiac
or cerebral malformations which are considered
difficult to detect, urinary abnormalities are more
readily visible, because they are most often associ-
ated with hypoechogenic adjunctive lesions.
Proper identification of the malformation can be
performed in a referral centre, allowing adequate
neonatal management in order to avoid recurrent
urinary tract infections and renal failure. It is then
obvious that systematic ultrasound examination
during the third trimester of pregnancy should be
recommended, since two thirds of the cases were
diagnosed beyond the 24th week in our series as
well as in others [17–21].
On the other hand, it is more difficult to
demonstrate that early neonatal surgical therapy
leads to a better outcome on a long term basis.
Nevertheless, published data tend to show that in-
fants presenting with uropathies detected later in
life suffer more frequently from recurrent urinary
tract infections [22–23]. These infections lead to a
higher risk of severe and definitive renal function
impairment. 
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